Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Antitumor sulfonamides claimed by Lilly

July 16, 2004

Elan to produce reformulated Panzem for EntreMed oncology program

July 16, 2004

Fourth phase II study of PI-88 launches

July 16, 2004

Encouraging results for MF-5232 for mucositis

July 16, 2004

Potent uPA inhibitor selected for clinical evaluation at Pfizer

July 16, 2004

Imiquimod in the treatment of AIN in HIV-infected men

July 16, 2004

Silicon compounds for the treatment of cancer reported by Amedis

July 15, 2004

Inhibitors of kinases claimed by Schering AG

July 15, 2004

Novel CDK inhibitors from BMS show in vivo anticancer activity

July 15, 2004

Oxford GlycoSciences claims antiangiogenic agents

July 14, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...